| scholarly article | Q13442814 |
| P50 | author | Consolato Sergi | Q45664416 |
| P2093 | author name string | Aiza Khan | |
| P2860 | cites work | Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis | Q24310793 |
| Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis | Q28256476 | ||
| Neuraminidase 1 is a negative regulator of lysosomal exocytosis | Q30486788 | ||
| Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation | Q31980558 | ||
| Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis | Q33587948 | ||
| Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice | Q33637287 | ||
| Lysosomal multienzyme complex: pros and cons of working together | Q33682632 | ||
| Sialidosis: a review of human neuraminidase deficiency | Q33898281 | ||
| Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex | Q33898327 | ||
| Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis | Q33924296 | ||
| Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient | Q34084901 | ||
| Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene. | Q34101168 | ||
| Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes | Q34112807 | ||
| Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient. | Q34133659 | ||
| Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis | Q34418454 | ||
| Pathological study on a severe sialidosis (alpha-neuraminidase deficiency). | Q36481831 | ||
| Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis | Q36649026 | ||
| Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis | Q37224436 | ||
| Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus. | Q38210178 | ||
| Sialidosis type I: ophthalmological findings. | Q38260885 | ||
| Sialidoses. | Q38952836 | ||
| Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult | Q39241410 | ||
| The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis | Q39296453 | ||
| Neuraminidase deficiency: case report and review of the phenotype | Q39772950 | ||
| Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression | Q40604011 | ||
| Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India. | Q42723830 | ||
| Positive regulation of insulin signaling by neuraminidase 1. | Q43090881 | ||
| Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene | Q43719873 | ||
| Mucolipidosis I — A sialidosis | Q43801611 | ||
| Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients | Q44810122 | ||
| Sialidase (alpha-n-acetyl neuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia | Q44975342 | ||
| Severe infantile sialidosis--the characteristics of oligosaccharides isolated from the urine and the abdominal ascites | Q44989094 | ||
| Histological, biochemical, and genetic characterization of early-onset fulminating sialidosis type 2 in a Korean neonate with hydrops fetalis | Q46126186 | ||
| Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots | Q46487106 | ||
| Short-term, high dose enzyme replacement therapy in sialidosis mice | Q46567099 | ||
| Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant | Q48142476 | ||
| Sialidosis type 2 (acid neuraminidase deficiency): clinical and biochemical features of a further case. | Q52103898 | ||
| NEU1 mutation in a Korean infant with type 2 sialidosis presenting as isolated fetal ascites. | Q53260096 | ||
| Type I sialidosis: a clinical, biochemical and neuroradiological study | Q57188866 | ||
| Congenital sialidosis | Q64050009 | ||
| Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts | Q67546931 | ||
| Urinary oligosaccharide excretion and severity of galactosialidosis and sialidosis | Q67833606 | ||
| Colour Doppler imaging of intracranial vasculopathy in severe infantile sialidosis | Q68023048 | ||
| [Fetal ascites as a manifestation of infantile sialidosis. Significance of a study of oligosaccharides in amniotic fluid] | Q68945583 | ||
| [Primary neuraminidase deficiency with prenatal disclosure] | Q69571241 | ||
| The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: possible linkage between HLA and the neuraminidase deficiency gene | Q69870952 | ||
| Congenital ascites as a presenting sign of lysosomal storage disease | Q70463452 | ||
| Infantile type 2 sialidosis in a Pakistani family--a clinical and biochemical study | Q70507675 | ||
| Mucolipidosis I (acid neuraminidase deficiency). Three cases and delineation of the variability of the phenotype | Q70895964 | ||
| A severe infantile mucolipidosis. Clinical, biochemical, and pathologic features | Q71243744 | ||
| Neuraminidase deficiency presenting as non-immune hydrops fetalis | Q72834626 | ||
| [Sialidosis and galactosialidosis as the cause of non-immunologic hydrops fetalis] | Q74083790 | ||
| Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice | Q74148100 | ||
| Clinical variability of type II sialidosis by C808T mutation | Q78775987 | ||
| Abnormal cortical excitability with preserved brainstem and spinal reflexes in sialidosis type I | Q80879905 | ||
| Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean? | Q81037873 | ||
| Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase | Q81772399 | ||
| [Anesthetic management of a boy with sialidosis] | Q83372118 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | molecular biology | Q7202 |
| sialidosis | Q55787312 | ||
| P577 | publication date | 2018-04-25 | |
| P1433 | published in | Diagnostics | Q27726498 |
| P1476 | title | Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder | |
| P478 | volume | 8 |
| Q99635692 | Bergmeister's papilla in a young patient with type 1 sialidosis: case report |
| Q89509285 | Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease |
| Q59336857 | Promptly reporting of critical laboratory values in pediatrics: A work in progress |
| Q92759083 | Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patients |
Search more.